Correction to: Whole-genome sequencing identifies responders to Pembrolizumab in relapse/refractory natural-killer/T cell lymphoma.

Autor: Lim JQ; State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.; Lymphoma Genomic Translational Research Laboratory, Cellular and Molecular Research, National Cancer Centre Singapore, Singapore, Singapore.; ONCO-ACP, Duke-NUS Medical School, Singapore, Singapore., Huang D; Lymphoma Genomic Translational Research Laboratory, Cellular and Molecular Research, National Cancer Centre Singapore, Singapore, Singapore.; ONCO-ACP, Duke-NUS Medical School, Singapore, Singapore., Tang T; Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore., Tan D; Raffles Cancer Centre, Raffles Hospital, Singapore, Singapore.; Department of Haematology, Singapore General Hospital, Singapore, Singapore., Laurensia Y; Lymphoma Genomic Translational Research Laboratory, Cellular and Molecular Research, National Cancer Centre Singapore, Singapore, Singapore., Peng RJ; State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China., Wong EKY; Lymphoma Genomic Translational Research Laboratory, Cellular and Molecular Research, National Cancer Centre Singapore, Singapore, Singapore., Cheah DMZ; Lymphoma Genomic Translational Research Laboratory, Cellular and Molecular Research, National Cancer Centre Singapore, Singapore, Singapore., Chia BKH; Lymphoma Genomic Translational Research Laboratory, Cellular and Molecular Research, National Cancer Centre Singapore, Singapore, Singapore., Iqbal J; Department of Pathology, Singapore General Hospital, Academia, Singapore., Grigoropoulos NF; Department of Haematology, Singapore General Hospital, Singapore, Singapore., Nairismägi ML; Lymphoma Genomic Translational Research Laboratory, Cellular and Molecular Research, National Cancer Centre Singapore, Singapore, Singapore., Ng CCY; Laboratory of Cancer Epigenome, Division of Medical Sciences, National Cancer Centre, Singapore, Singapore.; Division of Cancer and Stem Cell Biology, Duke-NUS Medical School, Singapore, Singapore., Rajasegaran V; Laboratory of Cancer Epigenome, Division of Medical Sciences, National Cancer Centre, Singapore, Singapore.; Division of Cancer and Stem Cell Biology, Duke-NUS Medical School, Singapore, Singapore., Hong H; State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.; Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China., Kim SJ; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea., Cho J; Department of Pathology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea., Tse E; Department of Medicine, The University of Hong Kong, Queen Mary Hospital, Pokfulam, Hong Kong., Mow B; Mount Elizabeth Medical Centre, Singapore, Singapore., Cai QC; Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China., Poon LM; Department of Haematology-Oncology, National University Cancer Institute of Singapore, National University Health System, Singapore, Singapore., Cai QQ; State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China., Tan J; State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.; Lymphoma Genomic Translational Research Laboratory, Cellular and Molecular Research, National Cancer Centre Singapore, Singapore, Singapore.; Laboratory of Cancer Epigenome, Division of Medical Sciences, National Cancer Centre, Singapore, Singapore., Chan JY; Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore., Lim JX; Department of Pathology, Singapore General Hospital, Academia, Singapore., Goh YT; Department of Haematology, Singapore General Hospital, Singapore, Singapore., Phipps C; Department of Haematology, Singapore General Hospital, Singapore, Singapore., Rötzschke O; Singapore Immunology Network (SIgN), A*STAR (Agency for Science, Technology and Research), Singapore, Singapore., Cheng CL; Department of Pathology, Singapore General Hospital, Academia, Singapore., Ha JCH; Lymphoma Genomic Translational Research Laboratory, Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore., Khoo LP; Lymphoma Genomic Translational Research Laboratory, Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore., Loh YSM; Raffles Cancer Centre, Raffles Hospital, Singapore, Singapore.; Department of Haematology, Singapore General Hospital, Singapore, Singapore., Au-Yeung R; Department of Pathology, The University of Hong Kong, Queen Mary Hospital, Pokfulam, Hong Kong., Chan TS; Department of Medicine, The University of Hong Kong, Queen Mary Hospital, Pokfulam, Hong Kong., Kwong YL; Department of Medicine, The University of Hong Kong, Queen Mary Hospital, Pokfulam, Hong Kong., Hwang W; Director's office, National Cancer Centre Singapore, Singapore, Singapore., Kim WS; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea., Bei JX; State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China., Lin T; State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China. tongyulin@hotmail.com.; Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China. tongyulin@hotmail.com., Ong CK; Lymphoma Genomic Translational Research Laboratory, Cellular and Molecular Research, National Cancer Centre Singapore, Singapore, Singapore. cmrock@nccs.com.sg.; Genome Institute of Singapore, Singapore, Singapore. cmrock@nccs.com.sg.; Duke-NUS Graduate Medical School, Singapore, Singapore. cmrock@nccs.com.sg., Lim ST; Director's office, National Cancer Centre Singapore, Singapore, Singapore. lim.soon.thye@singhealth.com.sg.; Office of Education, Duke-NUS Medical School, Singapore, Singapore. lim.soon.thye@singhealth.com.sg.
Jazyk: angličtina
Zdroj: Leukemia [Leukemia] 2021 Apr; Vol. 35 (4), pp. 1225.
DOI: 10.1038/s41375-021-01195-4
Databáze: MEDLINE